Clinical Trials Browser

Interventional × Neuroendocrine Tumors × pegfilgrastim × Clear all

NCT02943733 2022-09-23

Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs

Phase 1 Terminated

Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors